Introduction Frohlich, Edward D.; Reid, John L. Frohlich, Edward D.; Reid, John L. Less Journal of Hypertension. 15(5):S1, 1997. Favorite PDF Permissions Buy
Cardiovascular care with the new T-type calcium channel antagonist: Possible role of attendant sympathetic nervous system inhibition Bühler, Fritz R. Bühler, Fritz R. Less Journal of Hypertension. 15(5):S3-S7, 1997. Abstract Abstract Favorite PDF Permissions Buy
Cardiovascular T-type calcium channels: Physiological and pharmacological significance Triggle, David J. Triggle, David J. Less Journal of Hypertension. 15(5):S9-S16, 1997. Abstract Abstract Favorite PDF Permissions Buy
Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker Clozel, Jean-Paul; Ertel, Eric A.; Ertel, Sylvie I. Clozel, Jean-Paul; Ertel, Eric A.; Ertel, Sylvie I. Less Journal of Hypertension. 15(5):S17-S26, 1997. Abstract Abstract Favorite PDF Permissions Buy
Clinical relevance of optimal pharmacokinetics in the treatment of hypertension Meredith, Peter A. Meredith, Peter A. Less Journal of Hypertension. 15(5):S27-S32, 1997. Abstract Abstract Favorite PDF Permissions Buy
Differential properties of mibefradil in hypertension and angina Kobrin, Isaac Kobrin, Isaac Less Journal of Hypertension. 15(5):S33-S40, 1997. Abstract Abstract Favorite PDF Permissions Buy
Should a modern antihypertensive drug possess cardioprotective properties? Hansson, Lennart Hansson, Lennart Less Journal of Hypertension. 15(5):S41-S43, 1997. Abstract Abstract Favorite PDF Permissions Buy
